Tavneos 10 mg
As listed in the register: Tavneos 10 mg, Hartkapseln
10 mg ·
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Avacopanum
- Made by
- Vifor Fresenius Medical Care Renal Pharma Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Behandlung erwachsener Patienten mit schwerer aktiver Vaskulitis (Granulomatose mit Polyangiitis (GPA) oder mikroskopischer Polyangiitis (MPA))
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Vifor Fresenius Medical Care Renal Pharma Ltd. |
|---|---|
| Active substance | Avacopanum |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 10 mg |
| Classification | L04AJ05 · Cancer treatments and immune-system medicines |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Tavneos 10 mg, Hartkapseln |
| Packs | 30 Kapsel(n) · 180 Kapsel(n) |
| Zulassungsnummer | 66772 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.